Target intelligence / Profile preview

General transcription factor IIi pseudogene 2 (GTF2IP2)

Target
GTF2IP2
Molecular classification
pseudogene, non-coding pseudogene
01

Overview

General transcription factor IIi pseudogene 2 (GTF2IP2) is classified as a pseudogene. There is little to no functional information available for GTF2IP2 in authoritative biomedical databases or scientific literature, and it is not recognized as a canonical protein-coding gene, receptor, enzyme, or druggable therapeutic target. The protein-coding homolog is "General transcription factor IIi" (GTF2I), which encodes a transcription factor involved in gene regulation and cell signaling, but GTF2IP2 itself is annotated as a non-coding pseudogene, likely the result of a duplication or retrotransposition event. As a pseudogene, GTF2IP2 is not known to produce a functional protein or play a direct role in biological processes or diseases. There are no known drugs, mechanisms of action, or safety concerns associated with this entry[1][5]. Note: If you are seeking a therapeutic target or actionable molecule, the true target of interest may be GTF2I, not GTF2IP2.

Beyond the preview

Go deeper on General transcription factor IIi pseudogene 2 (GTF2IP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General transcription factor IIi pseudogene 2 (GTF2IP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call